Copyright 2019 Hubbard Radio Washington DC, LLC. All rights reserved. This website is not intended for users located within the European Economic Area.
ROCKVILLE, Md. (AP) _ GlycoMimetics Inc. (GLYC) on Friday reported a loss of $7.7 million in its first quarter.
On a per-share basis, the Rockville, Maryland-based company said it had a loss of 18 cents.
The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 30 cents per share.
The biotechnology company posted revenue of $9 million in the period.
The company’s shares closed at $2.79. A year ago, they were trading at $12.48.
Insight by PROPRICER: A new Federal News Network report demonstrates that DoD’s need for speed and accuracy means it has to update their acquisition processes and ensure it has quality data.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GLYC at https://www.zacks.com/ap/GLYC
Copyright © 2020 . All rights reserved. This website is not intended for users located within the European Economic Area.